Utama › Gangguan Depresi Major › Arkansas › Little Rock
Kajian klinikal Gangguan Depresi Major di Little Rock, AR
14 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi dalam dan sekitar Little Rock (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Mengambil pesertaFasa 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
Mengambil pesertaFasa 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi jauh
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Mengambil pesertaFasa 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 15 mi jauh
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Mengambil pesertaFasa 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Mengambil pesertaFasa 4
- Neurocrine Clinical Site, Bryant · 15 mi jauh
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Mengambil pesertaFasa 3
- SanRo Clinical Research Group, Bryant · 15 mi jauh
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Mengambil pesertaFasa 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Mengambil pesertaFasa 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Bryant · 15 mi jauh
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Mengambil pesertaFasa 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · 15 mi jauh
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Mengambil pesertaFasa 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Mengambil pesertaFasa 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Little Rock
Kajian Gangguan Depresi Major di bandar lain
- New York City, NY36 kajian
- Boston, MA31 kajian
- Atlanta, GA25 kajian
- Philadelphia, PA23 kajian
- Orlando, FL19 kajian
- Miami, FL18 kajian
- Chicago, IL17 kajian
- Tampa, FL17 kajian
- San Diego, CA16 kajian
- Houston, TX16 kajian
- Austin, TX13 kajian
- Las Vegas, NV13 kajian
Kajian lain di Little Rock
- Skizofrenia19 kajian
- Kanser (semua jenis)14 kajian
- Leukemia Mieloid Akut13 kajian
- Kanser Paru-paru Bukan Sel Kecil13 kajian
- Obesiti11 kajian
- Kanser Endometrium10 kajian
- Depresi10 kajian
- Diabetes Jenis 210 kajian
- Kanser Paru-paru9 kajian
- Penyakit Kardiovaskular9 kajian
- Kanser Pundi Kencing9 kajian
- Kegagalan Jantung9 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.